Pulmonary hypertension (PH) is associated with high morbidity and mortality and the predictive capacity of traditional functional echocardiographic measures is poor. Recent studies assessed the predictive capacity of right ventricular longitudinal strain (RVLS). Diversity in methods between these studies resulted in conflicting outcomes. The purpose of this systematic review and meta-analysis was to determine the independent prognostic value of RVLS for PH-related events and all-cause mortality.
Introduction
Pulmonary hypertension (PH) is a progressive disease with a 5-year survival rate of approximately 50%, depending on aetiology and disease severity. 1 Although the aetiology of PH relates to an increased pulmonary artery resistance, the primary cause of death relates to right ventricular (RV) failure since the right ventricle has to overcome the increased pulmonary resistance in order to maintain cardiac output. 2 Consequently, echocardiographic measurements of RV structure and function are routinely performed during follow-up of patients with PH. 3, 4 Due to complex RV geometry and load dependency of the RV functional parameters, traditional echocardiographic indices such as RV fractional area change (RVFAC) and tricuspid annular plane systolic excursion (TAPSE), have limited prognostic power in patients with PH. 3 The introduction of speckle tracking echocardiography has allowed for the measurement of ventricular longitudinal strain, a measure of ventricular deformation to assess specific local and global function. 5 In heart failure, valvular heart disease, cardiomyopathy and ischaemic heart disease, left ventricular longitudinal strain independently predicts future events. 6 Patients with PH demonstrate a reduced RV longitudinal strain (RVLS) compared with healthy controls, whilst several studies have examined the prognostic value of RVLS in patients with PH. These studies report a broad range of outcomes, ranging from no significant predictive capacity to a high predictive capacity. These differences in outcome may relate to differences in methodology between studies, such as variation in aetiology [PH vs. pulmonary arterial hypertension (PAH)], included population for hazard ratio (HR) calculation (inclusion of healthy controls or non-PH patient vs. just PH patients), patient management at time of inclusion (treatment naive vs. single or combined therapy), follow-up duration (0.6-5.0 years), outcome parameters (morbidity vs. all-cause mortality), group size (n = 17 up to n = 406), and methods in which the HRs were determined (percentile change (continuous parameter) vs. a predefined cut-off point (dichotomous parameter). [7] [8] [9] [10] [11] [14] [15] [16] [17] 21, 23, 24, 28, 29 The heterogeneity in study designs and outcomes provide a challenge when attempting to establish the potential prognostic value of RVLS in patients with PH. Combining these studies in a systematic review and meta-analysis will provide clarity on the prognostic value of RVLS in patients with PH. The purpose of this systematic review and meta-analysis was to determine the independent prognostic value of RVLS in patients with PH on PH-related events and all-cause mortality. We hypothesize that RVLS will have independent prognostic value in PH patients for PH-related events and all-cause mortality.
Methods

Search strategy
A systematic search was performed with the use of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement 2015 (PRISMA). 31 References of included articles were manually checked for possible eligible studies that were missed during the literature search.
Study selection
After the initial search, duplicates were eliminated from the database. Two authors (H.H. and G.K.) independently screened the remaining study titles and abstracts for eligibility using the predefined inclusion and exclusion criteria (Table 1) , resulting in 42 articles from which full text was assessed ( Figure 1 ). We included studies in which either RV free wall longitudinal strain (RVFWS) or RV global longitudinal strain (RVGLS) was evaluated as a predictor for a combined endpoint of mortality and PHrelated events or (all-cause) mortality. We excluded those studies, which did not perform Cox proportional HR analysis, or if the (independent) prognostic value of RVLS in PH patients was not reported. Additionally in order to ensure we determine the independent prognostic value of RVLS in patients with PH only, we excluded studies which performed Cox proportional HR analysis in a population which included non PH patients (i.e. healthy controls or suspected patients). Table 3) . For assessment of study quality, data regarding the echocardiographic assessment was gathered consisting of manufacturer, assessment software, echocardiographic window/image, included segments, methods of optimization and usage of the guidelines. When viable data was missing, an attempt was made to request missing data from the authors by email (n = 4 studies). Three out of four studies with missing data provided the requested information and were included in our meta-analysis ( Figure 1 ).
Data extraction
Study quality
All studies included in our meta-analysis were assessed for quality using the Quality In Prognosis Studies (QUIPS) checklist for measuring study quality by two authors (H.H. and G.K.). 32 The QUIPS checklist exists of 31 items divided over six domains; study participation, study attrition, prognostic factor measurement, outcome measurement, study confounding and statistical analysis and reporting. For each domain, several items were evaluated, after which the domain was scored for the presence of low, moderate or high risk of bias. As recommended, a predefined overall rating was applied. 32 Studies with a high risk of bias score in a single domain or > _3 scores of moderate risk of bias in different domains were rated as high risk of bias and excluded from this review (Supplementary data online, Table S1 ).
Echocardiographic assessment
To ensure high quality and consistency of the RVLS measurement we only included studies which reported adherence to the ASE guidelines for echocardiographic assessment of the right heart 33 and/or chamber quantification, 34 used a (focused) RV apical four chamber view and traced the endocardial border for RVLS determination. 
Statistical analysis
Review Manager 5.3 (Cochrane Community) was used to perform a meta-analysis of the reported multivariate HRs. The reported HRs [95% CI] were converted to a log (HR) and the complementing standard error (SE) using the formula:
The resulting values were inserted in the inverse variance method for calculation of HRs using a random effects analysis to calculate the mean weighted HR (95% CI) for all studies. Separate analysis were performed for (i) a combined endpoint of mortality and PH-related events and (ii) all-cause mortality. To provide further insight in the relation between RVLS and the risk for the combined endpoint or all-cause mortality, we calculated the relative reduction of RVLS (in percentage) for which the HR was determined. For this purpose, we defined the relative reduction of RVLS as: the difference between the mean RVLS of the PH patients above the cut-off point and the cut-off point (for dichotomous scales) or between the mean RVLS of the PH patients and the chosen amount of change in % strain (for continuous scales). The weighted mean relative reduction in RVLS and follow-up time was calculated by multiplying the relative % reduction of RVLS or months of follow-up with the number of 
included patients per study, after which the cumulative value was divided by the total number of patients included in each analysis.
Results
Study selection
During our search we identified 1558 potential articles for inclusion. After removal of duplicates, 1155 articles remained, from which title and abstract were screened for potential inclusion. Finally, a total of 42 studies were considered to be eligible for inclusion ( Figure 1) . After carefully reading through the full-texts, we identified 12 studies that met our inclusion criteria. [7] [8] [9] [10] [11] 14, 15, 21, 23, 26, 28, 29 From these 12 studies, six provided data on all-cause mortality, 9,10,14,15,23,28 from which one study did not report nor provide the results of multivariate analysis. 14 This study was therefore excluded from our metaanalysis. Seven studies reported data for the combined endpoint. 7, 8, 10, 11, 21, 26, 29 One study reported separate data for all-cause mortality and combined endpoint and was included for both analysis. 10 The remaining 11 studies included a total number of 1169 patients with PH. Studies included predominantly female patients (range 56-83%), with a mean age varying from 39 to 66 years. Details about the patient population, WHO class, NYHA class, and study design of studies that were included are summarized in Table 3 .
Study endpoints
Studies that examined the combined endpoint included 821 patients with PH, with a follow-up time ranging from 0. 21 balloon pulmonary angioplasty 21 and intensified PH medical therapy. 8, 11 Studies that explored all-cause mortality as the primary endpoint included a total of 399 patients with PH, with a follow-up time ranging from 2.0 to 3.8 years.
Echocardiographic assessment
All studies reported that strain was calculated from 2D or 3D grey scale apical four-chamber orientation, whilst one study performed both 2D and 3D-strain imaging. 28 Strain was calculated with a variety of software packages (EchoPAC, GE Medical Systems, n = 8; Syngo vector velocity imaging, Siemens, n = 2; 2D cardiac performance analysis, TomTec, n = 1). Ten out of 11 studies determined a multivariate HR for RVFWS, while 4 out of 11 studies determined the multivariate HR for RVGLS. Half of the studies (6 out of 11) reported the methods applied for image optimization (i.e. adjustment of image sector width, gain and greyscale), while 9 out of 11 studies reported a frame-rate of >40 frames/s for strain analysis.
Combined endpoint
Seven studies adopted a combined endpoint of mortality and PH-related events and had a mean follow-up time of 26 ± 17 months. Figure 2 ). Studies with a relative reduction below 10% of RVLS tended to be insignificant after multivariate analysis, while studies with a relative reduction larger than 10% of RVLS did present significantly higher HR's after multivariate analysis ( Figure 2 ).
All-cause mortality
Using data from univariate analysis, all five studies revealed a significant increased HR for RVLS in the prediction for future all-cause mortality after a mean follow-up time of 30 ± 9 months. Multivariate analysis revealed that a lower RVLS was associated with a significantly higher HR for all-cause mortality in all studies. 9, 10, 15, 23, 28 Combining all multivariate HRs, our meta-analysis revealed that a relative reduction of 22% (range -10% to -33%) of RVLS was associated with an increased risk (HR 2.96, 95% CI 2.00-4.38) for all-cause mortality ( Figure 3) . No clear relation between a larger relative reduction in % of RVLS and HR was present ( Figure 3) .
Discussion
The purpose of this systematic review and meta-analysis was to examine whether RVLS has prognostic value for future events in patients with PH. The key finding was that RVLS has independent prognostic value for all-cause mortality ( Figure 3) . To a lesser extent, RVLS also demonstrated independent predictive capacity for the combined endpoint of mortality and PH-related events ( Figure 2) . Collectively, these findings emphasize that RVLS is a valuable tool with independent prognostic value for all-cause mortality in PH patients.
Impact of PH on RVLS
The thin RV walls consist of longitudinal, circumferential and oblique oriented muscle fibres. 35 The free wall predominantly consists of transverse fibres with scanty subendocardial longitudinal oriented fibres, while in the septal wall the oblique fibres are in a helical shape. 35 Coiling and shortening of the helical-shaped oblique fibres determine the shortening of the RV, producing 80% of RV systolic function. In contrast, contraction of the transverse fibres accounts for just 20% of RV systolic function. 35 In a healthy RV, contraction is therefore predominantly driven by shortening of the RV in the longitudinal direction, 35, 36 highlighting the importance of examining RVLS 35 in clinical and research scenarios. In PH, an increase in afterload influences the mechanical function of the right ventricle, which subsequently leads to a decrease in longitudinal shortening, 37 indicating insufficient contraction and leading to a reduction of RV stroke volume. The increased afterload forces the right ventricle to adapt, causing either hypertrophy and/or increased contractility to preserve function and stroke volume. 38 Ultimately, however, these processes may lead to maladaptive remodelling, which causes dilation of the chamber and altering of the helical orientation of the oblique fibres, leading to (progressive) attenuation of function. 35 This maladaptive process ultimately contributes to clinical progression and/or mortality. The strong relation between an increase in afterload and/or ventricular maladaptation alongside a decrease in RVLS likely explains the strong and independent prognostic value for RVLS for all-cause mortality in PH patients. 
All-cause mortality vs. combined endpoint
Our meta-analysis revealed a lower predictive capacity for combined endpoints versus all-cause mortality. This difference may be explained by the fact that clinical events included in the analysis for the combined endpoint are heterogeneous and, therefore, not all events may directly relate to strain (hence, the lower predictive capacity). Other factors than cardiac strain (e.g. gas transfer in the lungs 39 ) may contribute to the occurrence of these clinical events. In addition, several studies included intensified PH medical therapy as a combined endpoint, whilst this unlikely relates to cardiac strain. Therefore, the diversity in clinical events included in the combined endpoint, but also the weak link between some of these factors and cardiac strain, lowers the discriminating capacity of RVLS to predict a combined endpoint vs. all-cause mortality.
Predictive capacity vs. a relative reduction in percentage of RVLS As shown in Figure 3 , there is no clear relation between the relative reduction in percentage of RVLS and the HR for all-cause mortality. This may be explained by the differences across study designs. In contrast to our expectations, the three studies with the lowest relative reduction in RVLS presented the highest HRs in the analysis for allcause mortality. These three studies all used a dichotomous cut-off value (between -17% and -20%) for RVLS, 9,15,28 which was higher than the mean RVLS value for the PH patients in the two remaining studies (i.e. -16.1% and -15%). 10, 23 The latter two studies calculated the HR per SD-unit change in RVLS, which resulted in a lower absolute cut-off (approximately -11.1% and -10%) value and in a higher incidence of mortality in the group above the cut-off value. In contrast to the cut-off values in the latter two studies, additional analysis to identify the ideal cut-off value in four out of these five studies showed that an absolute cut-off between -12.5% and -19.1% had the highest sensitivity and specificity to detect all-cause mortality in PH patients. 9, 10, 23, 28 This indicates that the calculated HR per SD-unit change underestimates the predictive value of RVLS in the latter two studies.
Future direction and clinical implications
Outcomes of the present meta-analysis supports the use of RVLS in patients with PH. Although RVLS has independent predictive value, recent strategies for predicting mortality and events in PH patients consists of constructing multi-parameter predictive models 40 including TAPSE and/or RFVAC to increase the predictive value in PH patients. 3, 41 Several studies included in our meta-analysis revealed RVLS to has superior predictive value over RVFAC and TAPSE, indicating that RVLS may be a more sensitive predictor for RV dysfunction. 8, 10, 15 Implementing RVLS in these multi-parameter predictive models therefore may increase their predictive value for future events. In addition to predicting future events, a relative reduction in RVLS might be indicative for (adjustment of) pharmacological therapy and/or surgery. Improvement of RVLS after pharmacological therapy and/or surgery has shown to be related to lower risks for mortality and PH-related events. 16, 24 These data further support the use of RVLS in clinical practice, as RVLS changes across time are associated to clinically relevant outcomes in PH patients. Future studies determining reference values and confirming clinically-relevant cut-off values are warranted to improve clinical decision-making and implementation of RVLS in practice.
Limitations
The studies within this meta-analysis were non-uniform in design and varied in the inclusion criteria, methods to measure RVLS (intervendor and technique variabilities), follow-up periods and endpoints. We corrected for these between-study variation using a random effects model in our meta-analysis. Additionally to minimize the impact of intervendor and technique variability we reported the relative reduction of percentage of RVLS rather than absolute values. We also included studies which used RVFWS (n = 7) and RVGLS (n = 1) or both (n = 3) to determine the predictive value of RVLS in PH patients. Unfortunately, the small amount of studies investigating RVGLS did not allow for a comparison between the predictive value of RVGLS and RVFWS. Similarly, we were not able to compare data obtained with 2D vs. 3D echocardiography and/or machines from different vendors. Due to differences in methodology and statistical approach, not all relevant studies could be included in our analysis. Studies using receiver operating characteristic curves, 18 
